Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Cash & Equivalents (2024 - 2025)

Historic Cash & Equivalents for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $175.4 million.

  • Kestra Medical Technologies' Cash & Equivalents rose 12806.63% to $175.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $175.4 million, marking a year-over-year increase of 12806.63%. This contributed to the annual value of $237.6 million for FY2025, which is 278028.85% up from last year.
  • Latest data reveals that Kestra Medical Technologies reported Cash & Equivalents of $175.4 million as of Q4 2025, which was up 12806.63% from $201.2 million recorded in Q3 2025.
  • In the past 5 years, Kestra Medical Technologies' Cash & Equivalents ranged from a high of $237.6 million in Q2 2025 and a low of $8.2 million during Q2 2024